Clinical trial
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia
NCT06560879 is registered in ClinicalTrials.gov with National Institute of Pediatrics, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia
- Lead sponsor
- National Institute of Pediatrics, Mexico
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- February 1, 2025
- Completion date
- August 31, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.